'
The related resources bookmark allows you to jump directly to other pages on the site that contain information directly related to the topics you're currently exploring.
- Home Page
- What's New?
- Tumor Types
- Molecular Causes of Cancer
- Biological Pathways
- Therapeutic Targets
- Pipeline Molecules
- Research Education
- Research ADCs
- Research Apoptosis
- Research B cell
- Research BRAF
- Research Cancer Immunotherapy
- Research HDIs
- Research HER Pathways
- Research MET
- Research VEGF
- Clinical Trials
- Resources
- Contact Us
Share
Initiating treatment
- Factors such as significant disease-related symptoms, bulky disease, and lymphocyte and platelet counts are important in determining when to initiate treatment12
- Disease stage and the presence of progressive disease also are important factors in deciding when to initiate therapy
- For patients with asymptomatic early-stage disease (Rai stage I or II, Binet stage A or B), a watch-and-wait approach has been suggested11,12,27
- Initiation of treatment is recommended for patients with symptomatic, advanced, or progressive disease,27 and intermediate- and high-risk disease9